Mr. Speaker, Canadians have endured so much since the start of the COVID-19 pandemic. Extended families have been separated, unable to see each other or travel because of the stringent restrictions that we need to follow to curb the spread of the virus. Many are feeling isolated and alone.
While we have seen some positive signs over the last few days that the spread is slowing, these past few months have been hard ones as we have experienced a resurgence of the virus. The pandemic continues to take a toll on all aspects of our lives, including our economic well-being and our mental and physical health. Many are unable to work, and of course many of our small business owners have had to close their doors while we grapple with bringing case numbers under control.
Our government has taken numerous measures to ensure that Canadians are supported in their time of need, and with that support we are laying the foundations for an economic recovery, one that will have Canada bounce back stronger than ever. I know that members agree that we need to do everything we can to get our economy back on track, and we all want that recovery to happen as soon as possible.
However, most importantly, we need to keep Canadians safe now. Since the first case was reported in Canada, nearly 20,000 Canadians have died from the virus. That number is a stark reminder of what is at stake here as we hold this emergency debate. Each one of those deaths represents a grieving family that has lost a loved one, be it a grandparent, a parent, a sibling or even a child, in so many cases not even having the opportunity to say goodbye. It is true that Canadians are tired of restrictions and limiting their contacts, but most are doing their part because they know the cost. They have been doing their part since day one, and our government has been doing everything it can to get us all through this unprecedented crisis.
Since the beginning, my department of Public Services and Procurement Canada has worked diligently to procure the necessary supplies to support our front-line health care workers. We worked non-stop to procure vital PPE and other medical supplies for front-line health care workers. This work was not easy. Global demand meant that early and urgent supplies largely came from overseas. However, Canadian industries stepped up, building domestic capacity so that many of our procurements are now Canadian-based. With over 2.5 billion individual pieces of PPE and medical equipment secured, we are increasingly returning to competitive procurements wherever feasible.
In this same competitive environment, we have also made great strides in purchasing much-needed COVID tests, including rapid testing, an important element for Canada's ongoing response. To date, we have delivered more than 15 million rapid tests for use by our provincial and territorial partners. Ultimately, though, we know that the only way out of this pandemic is by getting vaccines to Canadians as quickly as possible.
Our approach to procuring vaccines has been deliberate, strategic and comprehensive. At the outset of the pandemic, when pharmaceutical companies took on the challenge, none of us knew if it was even possible to develop a vaccine against COVID-19.
Once vaccine candidates began to show promise, we knew that we would be dealing with a highly complex and competitive global market. Scientists, manufacturers and regulators around the globe would be working under intense pressure to develop, produce and carefully assess safe and effective vaccines. Not unlike our experience in procuring medical supplies and equipment, we knew that we would be operating in a highly competitive marketplace. To say the least, the risks were high and the unknowns were many. For that very reason, starting last summer, we pursued a diversified vaccine procurement approach, one that allowed us to secure doses as early as possible by signing agreements in principle while the details for the final purchase agreement were being negotiated.
At the same time, we were proactive in acquiring critical goods and services such as needles, syringes and more in order to support the provinces and territories when it came time to administer the vaccines.
As a government, our decisions and our response to the pandemic have always been based on the best and most recent scientific understanding of the virus. Our work here was guided by our COVID-19 vaccine task force, the creation of which was a key element of our government's vaccine strategy early on. The task force is composed of experts and industry leaders, providing scientific and technical advice.
On the advice of this task force, we began signing agreements with potential suppliers as early as last July on behalf of the Public Health Agency of Canada. In all, our government managed to gain access to nearly 400 million doses of potential vaccines from seven different manufacturers, resulting in one of the most robust and diverse portfolios of COVID-19 vaccines in the world. Our goal was to solidify early access to a highly diversified portfolio so that Canada would be well positioned to receive doses quickly once they were deemed safe and effective.
In December, our approach began to pay off when Health Canada was close to authorizing the use of the Pfizer-BioNTech vaccine. We were similarly able to negotiate the arrival of doses earlier than scheduled. Similarly, Canada was successful in negotiating the delivery of the Moderna vaccine beginning in December, which proved important for distribution to indigenous and remote communities, given Moderna's less stringent refrigeration requirements.
Through our agreements with Pfizer and Moderna, we were guaranteed 20 million doses of each vaccine, with options to purchase more. Soon afterward, the vaccines began to roll in and, thanks to the flexibility of those agreements, we were able to exercise options for 20 million more doses of each. Because we laid the groundwork, because we took action as early a possible and because we took a strategic approach, one that would ensure the best outcome for Canadians, we have secured 80 million doses of authorized vaccines under contract to be delivered this year. I would add that when candidates from the five remaining manufacturers we have under agreement receive Health Canada approval, we will take a similar course of action, with a view to getting vaccines into this country as soon as possible.
As for timing, the shipments of Moderna and Pfizer we have secured are already bringing relief to communities across Canada, with vulnerable people in long-term care homes and health care workers being vaccinated. So far, we have received and distributed a total of 1.1 million COVID-19 vaccine doses to the provinces and territories. It has been truly a team Canada approach; thanks to the work of the provinces and territories, vaccines are now getting into the arms of Canadians.
Just as I have committed to being transparent and up front with Canadians about our progress on vaccines, I am also committed to being up front with Canadians when issues arise. As I have said, we have always known that we would be operating in a highly complex and intensely competitive environment. We knew that vaccine manufacturers would need to ramp up production at unprecedented speeds as they fielded orders from around the world. That is why we pursued a number of agreements early on in the pandemic when the vaccines began to show promise so that Canada would have more security through a diversified portfolio.
When Pfizer informed us that there would be a temporary delay in its shipments, starting this week, I was disappointed and frustrated, to say the least. My team has been in direct communication with Pfizer, as have I, to make sure that Pfizer meets its commitments.
I can also assure the House that I have personally been in contact with Pfizer almost daily to firmly reiterate the importance, for Canada, of returning to our regular delivery schedule as soon as possible. It is important to note that the temporary delay in deliveries is so that Pfizer can increase its production capacity. We can expect a ramp-up of deliveries of the vaccine following this disruption.
It is also important to note that Canada is far from the only country impacted by the disruption. All countries supplied by Pfizer's European facility have had their shipments impacted. Pfizer has confirmed that while the next few weeks will be challenging when it comes to deliveries, hundreds of thousands of doses will be delivered the week of February 15 and in the weeks that follow. It has also confirmed that we will receive all four million doses owed to us in the first quarter of this year, on time, before March 31.
Between Moderna and Pfizer, we still anticipate receiving six million doses of COVID-19 vaccines by the end of March. After that, we can expect a significant acceleration in the delivery of authorized vaccines. From April to June, we expect that at least 20 million doses of vaccines will be available to Canadians from coast to coast to coast.
Between Pfizer and Moderna alone, we remain on track to have enough vaccines by the end of September for everyone in Canada who is eligible and wants to be vaccinated. We also continue to follow developments concerning vaccine candidates from the five other manufacturers with whom we have agreements: Sanofi-GSK, Medicago, AstraZeneca, Johnson & Johnson, and Novavax. I can tell Canadians that we will continue to pursue even more doses through these agreements as more vaccine candidates are deemed safe and effective, with a view to getting them into Canada as quickly as possible.
The toll that COVID-19 has taken on our citizens and our economy has been devastating. I have to reiterate that there is a light at the end of the tunnel. We are on our way to getting through this. The vaccines are here and more will arrive very soon. In working with the provinces and territories, we have established supply chains to get vaccines into the arms of Canadians as soon as possible.
The immunization effort will be one of the greatest undertakings in this country's history, but it will not happen overnight and there will be bumps along the way. I will always be transparent and upfront with Canadians about the status of our efforts, and while the global market is complex and can be unstable at times, the fact is that now we can see a way out of this pandemic.
We are in the final stretch, with vaccines being rolled out. As the Prime Minister reported to Canadians on Friday, Canada is now approaching three-quarters of a million vaccine doses administered across the country. The average number of doses administered daily is now almost four times what it was just three weeks ago.
There is more work to do, and we must remain vigilant. For Canadians, that means continuing to follow guidelines from our local health officials, doing everything we can to limit our contacts and once again flatten the curve. It will not be easy, but our actions quite literally will be saving lives over these winter months. For our government and for all members of the House, it means continuing to support Canadians in their time of need. As we returned to the House yesterday, it marked one year since the first recorded case of COVID-19 in Canada.
Not many of us here could have anticipated what the past year would look like, but we found a way to come together in the face of such adversity. Our work is by no means done. Yes, the vaccines are arriving and Canadians are doing their part to flatten the curve until we can inoculate everyone who wants a vaccine.
Thanks to our efforts so far, through our collaboration in the House, working with provinces and territories and because of our team Canada approach, we are making progress. By this time next year, my sincere hope is that the pandemic will be behind us once and for all.
While I appreciate the fact that this emergency debate is addressing the most pressing issue facing our nation, now is not the time for scoring political points. The fact is that we are getting the job done when it comes to vaccines, and despite bumps in the road we are on track to meet our goal of inoculations being available to every eligible Canadian who wants one by September. I know that if we can keep working for Canadians together, we will get through this and we will make our hopes a reality.